Sign in
CompletedNo phase

Cuff Pressure Control and Evacuation of Subglottic Secretions To Prevent Pneumonia

Key facts

Who runs it
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Where
Israel and Italy11 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
270 people enrolled
Started
6 Jun 2022
Ended
9 Apr 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Continuous cuff pressure regulation
  • Intermittent cuff pressure regulation
  • Automatic subglottic secretion drainage
  • Manual subglottic secretion drainage
  • Tracheobronchial colonization assessment
  • Microaspiration assessment
  • VAP assessment
Record updated
7 May 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Primary intubation with the study ETT
  • Expected duration of mechanical ventilation >48 hours
  • Age older than 18 years

Who cannot take part

  • Invasive mechanical ventilation in the last 14 days,
  • Contraindication for enteral feeding
  • Clinical evidence of inhalation before intubation
  • Pregnancy
  • Enrolling in another study that may interfere with this trial

This trial has no sites in United States.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

Multicenter, cluster randomized, controlled, open-label trial to assess if AnapnoGuard System can minimize tracheal microaspiration and the risk of ventilator-associated pneumonia when compared to standard treatment

The 2 groups in the trial

  • AnapnoGuard groupTreatment being tested

    Patients intubated with AnapnoGuard endotracheal tube (polyvinylchloride tube with ellipsoidal shape, thin wall polyurethane cuff with dual suction lines and an extra venting line) which is connected to AnapnoGuard 100 System

    Treatment: Continuous cuff pressure regulation, Automatic subglottic secretion drainage, Tracheobronchial colonization assessment, Microaspiration assessment, and VAP assessment

  • Control groupExisting treatment, for comparison

    Patients intubated with TaperGuard Evac endotracheal tube (polyvinylchloride conic cuff with additional lumen for subglottic secretion suctioning)

    Treatment: Intermittent cuff pressure regulation, Manual subglottic secretion drainage, Tracheobronchial colonization assessment, Microaspiration assessment, and VAP assessment

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
An Innovative Cuff Pressure Control and Evacuation of Subglottic Secretions To Prevent Pneumonia. A Multicenter Cluster-Randomized Trial
Record updated
7 May 2024